threonine has been researched along with Cancer of Prostate in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 9 (33.33) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, MAP; Batista, AA; Campos, VNS; das Chagas Alves Lima, F; de Azevedo Dos Santos, APS; de Sousa, IH; Leite, CM; Lopes, AJO; Maciel-Silva, VL; Mourão, PS; Pereira, SRF; Vale, AAM | 1 |
| Chen, G; Cho, YC; Kim, H; Kim, K; Lee, HJ; Shen, Y; Zhou, R | 1 |
| Baker, MR; Banerjee, T; Barish, GD; Chakravarti, D; Kim, JY; Luo, Q; Parker, JB; Radhakrishnan, I; Vinckevicius, A; Wei, JJ | 1 |
| Bethard, JR; Ghose, S; Krupenko, NI; Krupenko, SA; Oleinik, NV; Peterson, YK; Prakasam, A | 1 |
| Hyland, PB; Kinsella, BT; Mulvaney, EP; O'Sullivan, AG | 1 |
| Cang, S; Chiao, JW; Liu, D; Ma, Y; Xu, X | 1 |
| Allory, Y; Carpentier, G; Céraline, J; Courty, J; De La Taille, A; Destouches, D; Maillé, P; Marchand, C; Sader, M; Semprez, F; Soyeux, P; Terry, S; Vacherot, F | 1 |
| Brady, SN; Gwinn, AS; Maggi, LB; Pelletier, CL; Toso, EA; Weber, JD; Winkeler, CL | 1 |
| Pienta, KJ; Roca, H; Varsos, ZS | 1 |
| Samelson, BK; Scott, JD; Smith, FD | 1 |
| Bossus, M; Ducancel, F; Jolivet-Reynaud, C; Michel, S; Muller, BH; Stura, EA | 1 |
| Balaji, KC; Biswas, MH; Du, C; Li, Z; Zhang, C | 1 |
| Cinar, B; Collak, FK; Erkaya, B; Luthringer, DJ; Yagiz, K | 1 |
| Agoulnik, IU; Buchanan, G; Harris, JM; James, AJ; Lamb, DJ; Marcelli, M; Tilley, WD; Weigel, NL | 1 |
| Boyle, P; English, DR; Giles, GG; Hopper, JL; McCredie, MR; Morris, H; Neufing, P; Severi, G; Southey, MC; Tesoriero, A; Tilley, W | 1 |
| Adler, D; Fick, G; Hughes, RM; Kanji, N; Trpkov, K | 1 |
| Abrahamsson, PA; Ahlgren, G; Gadaleanu, V; Giwercman, A; Giwercman, YL | 1 |
| Bergerat, JP; Céraline, J; Cruchant, M; Jacqmin, D; Jagla, M; Lapouge, G; Monge, A; Sasorith, S; Wurtz, JM | 1 |
| Ip, C; Wallace, PK; Warren, MA; Wu, Y; Zu, K | 1 |
| Cedazo-Minguez, A; Chuan, YC; Flores-Morales, A; Norstedt, G; Pang, ST; Pousette, A | 1 |
| Blouin, MJ; Levitt, RJ; Pollak, M; Zhao, Y | 1 |
| Altshuler, D; Bell, DW; Daly, MB; Freedman, ML; Garber, JE; Godwin, AK; Haber, DA; Haiman, CA; Harris, PL; Haserlat, SM; Henderson, BE; Kim, SH; Le Marchand, L; Niendorf, KB; Olopade, OI; Schiripo, TA; Sgroi, DC; Smith, MR; Wahrer, DC | 1 |
| Chen, H; Fazli, L; Gleave, ME; Guo, Z; Linn, DE; Nakanishi, T; Qiu, Y; Ross, DD; Shimelis, H; Xie, Y; Xu, K; Yang, X | 1 |
| Buettner, R; Fischer, K; Friedrichs, N; Higgins, JM; Kunowska, N; Metzger, E; Patnaik, D; Potier, N; Scheidtmann, KH; Schüle, R; Wissmann, M; Yin, N | 1 |
| Berrevoets, CA; Mulder, E; Veldscholte, J | 1 |
| Masai, M; Sato, N; Seino, S; Shimazaki, J; Suzuki, H; Watabe, Y | 1 |
| An, Y; Attar, RM; Einspahr, HM; Kiefer, SE; Kish, KF; Krystek, SR; Sack, JS; Salvati, ME; Scheffler, JE; Wang, C; Weinmann, R; Wu, GY | 1 |
1 review(s) available for threonine and Cancer of Prostate
| Article | Year |
|---|---|
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
Topics: Aged; Alanine; Case-Control Studies; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Leucine; Linear Models; Logistic Models; Male; Middle Aged; Neoplasm Proteins; Odds Ratio; Polymorphism, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Research Design; Risk Assessment; Risk Factors; Serine; Threonine | 2003 |
26 other study(ies) available for threonine and Cancer of Prostate
| Article | Year |
|---|---|
Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells.
Topics: Amino Acid Transport System ASC; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Chelating Agents; DNA Damage; Female; Genomic Instability; Humans; Ligands; Male; Minor Histocompatibility Antigens; Molecular Docking Simulation; Proline; Prostatic Neoplasms; Ruthenium Compounds; Threonine | 2020 |
δ-Catenin Participates in EGF/AKT/p21
Topics: Active Transport, Cell Nucleus; Binding Sites; Catenins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Delta Catenin; Epidermal Growth Factor; Humans; Ligands; Male; Models, Biological; Mutagenesis, Site-Directed; Neoplasm Invasiveness; PC-3 Cells; Phosphorylation; Prostatic Neoplasms; Protein Interaction Domains and Motifs; Protein Stability; Proto-Oncogene Proteins c-akt; Signal Transduction; Threonine | 2021 |
A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HeLa Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Male; Methylation; Myeloid-Lymphoid Leukemia Protein; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Receptors, Androgen; Signal Transduction; Threonine | 2014 |
JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1.
Topics: Aldehyde Dehydrogenase; Amino Acid Motifs; BH3 Interacting Domain Death Agonist Protein; Caspase 8; Cell Line, Tumor; Humans; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Oxidoreductases Acting on CH-NH Group Donors; Phosphorylation; Prostatic Neoplasms; Threonine | 2014 |
Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Signal Transduction; Threonine; Thromboxane A2; Time Factors; Transfection | 2015 |
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
Topics: Acetylation; Amino Acid Sequence; Butyric Acid; Cell Line; Cell Line, Tumor; Chromatography, Liquid; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Lysine; Male; Methylation; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Tandem Mass Spectrometry; Threonine | 2016 |
Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Humans; Male; Mice, Nude; Nuclear Proteins; Nucleophosmin; Nucleoproteins; Peptides; Phosphorylation; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Receptors, Androgen; Taxoids; Threonine; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Female; Green Fluorescent Proteins; HeLa Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Knockout; Mutation; NIH 3T3 Cells; Nuclear Proteins; Nucleophosmin; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; RNA Interference; Threonine; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2009 |
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
Topics: AMP-Activated Protein Kinases; Blotting, Western; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Chemokine CCL2; Enzyme Activation; Furans; Humans; Inhibitor of Apoptosis Proteins; Male; Mechanistic Target of Rapamycin Complex 1; Microtubule-Associated Proteins; Multiprotein Complexes; Phosphorylation; Prostatic Neoplasms; Proteins; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Survivin; Threonine; TOR Serine-Threonine Kinases; Transcription Factors | 2009 |
Discovery of cellular substrates for protein kinase A using a peptide array screening protocol.
Topics: Amino Acid Motifs; Amino Acid Sequence; Blotting, Western; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; DNA-Binding Proteins; Humans; LIM Domain Proteins; Male; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Protein Array Analysis; Protein Kinase C; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Sequence Homology, Amino Acid; Serine; Substrate Specificity; Threonine; Tumor Cells, Cultured | 2011 |
Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Asparagine; Crystallography, X-Ray; Glycosylation; Humans; Kallikreins; Male; Models, Molecular; Molecular Sequence Data; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Structure, Secondary; Semen; Threonine | 2011 |
Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network.
Topics: beta Catenin; Cell Line, Tumor; Humans; Immunohistochemistry; Male; Phosphorylation; Prostate; Prostatic Neoplasms; Threonine; trans-Golgi Network; Wnt Signaling Pathway | 2012 |
Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Chromones; HEK293 Cells; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Nude; Morpholines; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA Interference; Signal Transduction; Sirolimus; Threonine; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Tumor Burden | 2012 |
A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity.
Topics: Alanine; Animals; Binding Sites; Biological Transport; Cell Nucleus; COS Cells; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Stability; Gene Expression; Heat-Shock Proteins; Humans; Male; Metribolone; Models, Molecular; Mutation; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Structure-Activity Relationship; Testosterone; Threonine; Transcription, Genetic; Transfection | 2002 |
HPC2/ELAC2 gene variants associated with incident prostate cancer.
Topics: Age Factors; Alleles; Genetic Predisposition to Disease; Genetic Variation; Genotype; Heterozygote; Homozygote; Humans; Leucine; Logistic Models; Male; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Risk; Serine; Threonine | 2003 |
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Alanine; Alleles; Arginine; Biomarkers, Tumor; Case-Control Studies; Dihydrotestosterone; Disease Progression; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Luteinizing Hormone; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Risk Factors; Sex Hormone-Binding Globulin; Sweden; Terminal Repeat Sequences; Testosterone; Threonine; Valine | 2005 |
Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer.
Topics: Androgen Antagonists; Animals; Chlorocebus aethiops; COS Cells; Flutamide; Genes, Reporter; Humans; Luciferases; Male; Mutation; Prostatic Neoplasms; Receptors, Androgen; Response Elements; Steroids; Threonine | 2006 |
Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Antineoplastic Agents; Calcineurin; Calcium; Cell Membrane; Humans; Male; Organoselenium Compounds; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Selenium; Threonine | 2006 |
Androgen induction of prostate cancer cell invasion is mediated by ezrin.
Topics: Amino Acid Substitution; Androgens; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Collagen; Cytoskeletal Proteins; Drug Combinations; Humans; Laminin; Male; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Proteoglycans; Threonine; Tyrosine | 2006 |
The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Hedgehog Proteins; Humans; Insulin-Like Growth Factor II; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Threonine; Up-Regulation; Veratrum Alkaloids | 2007 |
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
Topics: Adult; Age of Onset; Aged; Asian People; Black or African American; Breast Neoplasms; Case-Control Studies; Checkpoint Kinase 2; DNA Mutational Analysis; DNA, Complementary; Female; Gene Frequency; Genetic Predisposition to Disease; Germ-Line Mutation; Hawaii; Hispanic or Latino; Histidine; Humans; Isoleucine; Leucine; Male; Middle Aged; Mutation; Mutation, Missense; Predictive Value of Tests; Proline; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Risk Assessment; Risk Factors; Threonine; Tyrosine; United States; White People | 2007 |
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.
Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Membrane; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Sequence Data; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Threonine; Two-Hybrid System Techniques | 2008 |
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.
Topics: Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromatin; Chromatin Immunoprecipitation; Gene Expression Regulation; Histones; Humans; Immunohistochemistry; Male; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Kinase C; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Threonine; Tissue Array Analysis; Transcription, Genetic; Transcriptional Activation | 2008 |
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Androgen Antagonists; Anilides; Animals; Blotting, Western; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Male; Metribolone; Mutagenesis, Site-Directed; Nitriles; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Threonine; Tosyl Compounds; Transcription, Genetic; Transfection; Transformation, Genetic; Tumor Cells, Cultured | 1993 |
Androgen receptor gene mutations in human prostate cancer.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Base Sequence; DNA Primers; DNA-Binding Proteins; DNA, Neoplasm; Exons; Genetic Variation; Histidine; Humans; Leucine; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Prostatic Neoplasms; Receptors, Androgen; Threonine | 1993 |
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.
Topics: Amino Acid Sequence; Amino Acid Substitution; Androgens; Animals; Binding Sites; Crystallography, X-Ray; Dihydrotestosterone; Dimerization; Humans; Ligands; Male; Models, Molecular; Molecular Sequence Data; Mutation; Progesterone; Prostatic Neoplasms; Protein Structure, Tertiary; Rats; Receptors, Androgen; Receptors, Progesterone; Sequence Alignment; Substrate Specificity; Threonine; Tumor Cells, Cultured | 2001 |